Oncaspar 750 UI/ml, poudre pour solution injectable

7680669340018 CH-66934 poudre pour solution injectable
Oncaspar 750 UI/ml, poudre pour solution injectable
Oncaspar 750 UI/ml, poudre pour solution injectable
Oncaspar 750 UI/ml, poudre pour solution injectable
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
poudre pour solution injectable
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
06/02/2025
Summary of Product Characteristics
Français
06/02/2025
Summary of Product Characteristics
Italien
06/02/2025

Detailed composition

Substance Quantity Type Category
(N/A)
3750.0 UI Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 1765.30
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/10/2019

Authorization holder

Servier (Suisse) SA

1202 Genève

Authorization information

Swissmedic authorization number
66934
Drug name
Oncaspar, poudre pour solution injectable
Galenic form
PULPA
ATC Code
L01XX24
Authorization status
Z
Dispensing category
A
First authorization
10/12/2018
Authorization expiration date
31/12/9999
IT Number
07.16.1.
Domain
Human medicine
Field of application
Oncaspar ist als Bestandteil einer antineoplastischen Kombinationstherapie bei akuter lymphatischer Leukämie (ALL) angezeigt

Package details

Description (FR)
ONCASPAR subst sèche 3750 UI flac
Description (DE)
ONCASPAR Trockensub 3750 IE Durchstf
Market launch
10/12/2018
Narcotic (BTM)
No